ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,286.40
      -0.10%
      Dow Jones
      40,421.36
      0.33%
      Brent Oil
      81.42
      -0.12%
      Bitcoin
      66,912.03
      -1.02%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Merus NV (MRUS) Quote

      Merus NV

      Merus NV (MRUS)

      NASDAQ
      55.80
      0.51
      (0.92%)
      Closed July 22 4:00PM
      Delayed by 15 minutes
      55.78
      0.00
      ( 0.00% )
      Pre Market: 4:09AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      55.78
      Bid
      22.43
      Ask
      60.00
      Volume
      -
      0.00 Day's Range 0.00
      19.805 52 Week Range 61.61
      Market Cap
      3.274B
      Previous Close
      55.78
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,076,960
      Shares Outstanding
      58,687,551
      Dividend Yield
      -
      PE Ratio
      -
      Earnings Per Share (EPS)
      -
      Revenue
      -
      Net Profit
      -

      About Merus NV

      Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus only reportable segment comprising the discovery and development of innovative ... Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus only reportable segment comprising the discovery and development of innovative bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others. Show more

      Sector
      Gen Med & Surgical Hospitals
      Industry
      Gen Med & Surgical Hospitals
      Website
      www.merus.nl
      Headquarters
      Utrecht, Utrecht, Nld
      Founded
      1970
      Merus NV is listed in the Gen Med & Surgical Hospitals sector of the NASDAQ with ticker MRUS. The last closing price for Merus NV was $55.78. Over the last year, Merus NV shares have traded in a share price range of $ 19.805 to $ 61.61.

      Merus NV currently has 58,687,551 shares outstanding. The market capitalization of Merus NV is $3.27 billion.

      Merus NV (MRUS) Options Flow Summary

      MRUS Options Flow

      Overall Flow

      Bullish

      Net Premium

      233k

      Calls / Puts

      100.00%

      Buys / Sells

      0.00%

      OTM / ITM

      100.00%

      Sweeps Ratio

      0.00%

      MRUS Latest News

      More News

      Merus Announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 2L CRC

      UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing...

      July 08 2024
      GlobeNewswire Inc.

      Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer

      UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing...

      July 01 2024
      GlobeNewswire Inc.

      Form 144 - Report of proposed sale of securities

      June 17 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 12 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 06 2024
      Edgar (US Regulatory)

      Merus’ MCLA-129 Demonstrates Promising Single-Agent Efficiency in METex14 NSCLC in Poster Presentation at the 2024 ASCO® Annual Meeting

      UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing...

      June 03 2024
      GlobeNewswire Inc.

      Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting

      UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 02, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing...

      June 02 2024
      GlobeNewswire Inc.

      Form 424B5 - Prospectus [Rule 424(b)(5)]

      May 30 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-2.32-3.9931153184258.159.3853.9275909656.5655063CS
      4-1.22-2.140350877195760.550.5186661856.33568712CS
      1210.6223.516386182545.1661.6142.6107696053.65141091CS
      2620.6258.64618885135.1661.6133.681637149.59944385CS
      5229.71113.96240889926.0761.6119.80559913441.61656006CS
      15637.27201.35062128618.5161.6112.0341372031.72579411CS
      26040.5265.05235602115.2861.6110.1829776129.39667194CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NMHINatures Miracle Holding Inc
      $ 0.8398
      (139.94%)
      		7.95M
      WRNTWarrantee Inc
      $ 0.5991
      (105.88%)
      		8.06M
      FEIMFrequency Electronics Inc
      $ 13.75
      (36.14%)
      		115.83k
      TUSKMammoth Energy Services Inc
      $ 4.50
      (28.57%)
      		65.83k
      LGHLWLion Group Holding Ltd
      $ 0.0091
      (28.17%)
      		4.5k
      RNAZTransCode Therapeutics Inc
      $ 0.3274
      (-58.69%)
      		418.09k
      MIRAMIRA Pharmaceuticals Inc
      $ 3.49
      (-30.34%)
      		943.44k
      CMAXCareMax Inc
      $ 3.82
      (-26.40%)
      		323.75k
      BREABrera Holdings PLC
      $ 0.5754
      (-21.94%)
      		1.74M
      NUKKNukkleus Inc
      $ 0.3998
      (-19.72%)
      		147.77k
      WRNTWarrantee Inc
      $ 0.5851
      (101.07%)
      		8.07M
      NMHINatures Miracle Holding Inc
      $ 0.8452
      (141.49%)
      		7.97M
      LIFWMSP Recovery Inc
      $ 0.5675
      (12.00%)
      		4.38M
      BREABrera Holdings PLC
      $ 0.577
      (-21.72%)
      		1.74M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 14.50
      (1.47%)
      		1.49M

      MRUS Discussion

      View Posts
      Phosphene Phosphene 4 years ago
      Merus and myTomorrows Announce Expansion of Collaboration for Screening and eNRGy Clinical Trial Awareness for Cancer Patients with Neuregulin 1 Fusion Tumors

      https://www.globenewswire.com/news-release/2020/10/12/2107078/0/en/Merus-and-myTomorrows-Announce-Expansion-of-Collaboration-for-Screening-and-eNRGy-Clinical-Trial-Awareness-for-Cancer-Patients-with-Neuregulin-1-Fusion-Tumors.html
      👍️0
      Phosphene Phosphene 4 years ago
      The Baker Brothers have 7% ownership.

      https://whalewisdom.com/filer/baker-bros-advisors-llc#tabholdings_tab_link
      👍️0
      Phosphene Phosphene 4 years ago
      Board Member: Victor Sandor

      https://ir.merus.nl/board-member/victor-sandor

      https://www.businesswire.com/news/home/20200824005127/en/Prelude-Therapeutics-Announces-Closing-50M-Series-Financing
      👍️0
      Phosphene Phosphene 4 years ago
      Second Quarter 2020 Results:

      https://www.globenewswire.com/news-release/2020/08/06/2074649/0/en/Merus-Announces-Financial-Results-for-the-Second-Quarter-and-Provides-Business-Update.html
      👍️0
      Phosphene Phosphene 4 years ago
      https://merus.nl/
      👍️0
      Phosphene Phosphene 4 years ago
      European cancer biotech Merus nabs Sanofi I-O chief Andrew Joe

      https://www.fiercebiotech.com/biotech/european-cancer-biotech-merus-nabs-sanofi-i-o-chief-andrew-joe
      👍️0

      Your Recent History

      NASDAQ
      MRUS
      Merus NV
      BIT
      UB5UKA
      Unicredit Bank
      COIN
      FIROBTC
      Firo
      Delayed Upgrade Clock